Necrotizing pneumonia caused by Panton-Valentine leucocidin-producing Staphylococcus aureus originating from a Bartholin's abscess.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 2492175)

Published in Infect Dis Obstet Gynecol on January 01, 2008

Authors

N Jung1, C Lehmann, M Hellmann, H Seifert, M M Valter, M Hallek, G Fätkenheuer, M Kochanek

Author Affiliations

1: Department I of Internal Medicine, University of Cologne, 50935 Cologne, Germany. norma.jung@uni-koeln.de

Articles cited by this

Staphylococcus aureus infections. N Engl J Med (1998) 36.39

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis (1999) 19.52

Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet (2002) 10.26

Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science (2007) 7.06

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis (2005) 6.85

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis (2004) 6.13

Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol (2006) 5.97

Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis (2006) 2.52

Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol (1995) 2.25

Septic shock complicating drainage of a Bartholin gland abscess. Obstet Gynecol (1990) 1.51

Intrafamilial spread of highly virulent staphylococcus aureus strains carrying the gene for Panton-Valentine leukocidin. Scand J Infect Dis (2002) 1.46

Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect (2008) 1.37

Progressive synergistic bacterial gangrene arising from abscesses of the vulva and Bartholin's gland duct. Am J Obstet Gynecol (1972) 1.36

In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. Clin Infect Dis (2007) 1.35

The current spectrum of Staphylococcus aureus infection in a tertiary care hospital. Medicine (Baltimore) (1994) 1.13

Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents (2007) 1.12

Gynecologic infections. Emerg Med Clin North Am (2003) 1.11

Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents (2001) 1.06

Aerobic and anaerobic microbiology of Bartholin's abscess. Surg Gynecol Obstet (1989) 1.04

Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis (2007) 1.02

Management of Bartholin's duct cyst and gland abscess. Am Fam Physician (2003) 0.98

Necrotizing fasciitis due to a methicillin-sensitive Staphylococcus aureus isolate harboring an enterotoxin gene cluster. J Clin Microbiol (2006) 0.95

Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia. BMJ (2005) 0.95

Severe pyomyositis caused by Panton-Valentine leucocidin-positive methicillin-sensitive Staphylococcus aureus complicating a pilonidal cyst. Langenbecks Arch Surg (2007) 0.94

Escherichia coli endotoxic shock complicating Bartholin's gland abscess. Can Med Assoc J (1980) 0.90

Severe sepsis and septic shock in the emergency department. Infect Dis Clin North Am (2008) 0.89

Toxic shock-like syndrome associated with Bartholin's gland abscess: case report. Am J Obstet Gynecol (1989) 0.87

Purpura fulminans in a child secondary to Panton-Valentine leukocidin-producing Staphylococcus aureus. J Med Microbiol (2007) 0.82

Fatal sepsis and necrotizing pneumonia in a child due to community-acquired methicillin-resistant Staphylococcus aureus: case report and literature review. Scand J Infect Dis (2005) 0.81

Office management of Bartholin gland cysts and abscesses. Am Fam Physician (1998) 0.81

Necrotizing fasciitis arising from Bartholin's abscess. Case report and review of the literature. Isr J Med Sci (1989) 0.81

Fatal Staphylococcus aureus haemorrhagic pneumonia producing Panton-Valentine leucocidin. Scand J Infect Dis (2007) 0.78

[Necrotizing fasciitis of the perineum secondary to a surgical treatment of Bartholin's gland abscess]. Gynecol Obstet Fertil (2005) 0.77

[Postoperative complications of Bartholin's duct abscess. About two cases]. Gynecol Obstet Fertil (2006) 0.77

[Laboratory and clinical studies on cefotaxime in obstetrics and gynecology (author's transl)]. Jpn J Antibiot (1981) 0.77

Sepsis after Bartholin's duct abscess marsupialization in a gravida. J Reprod Med (2001) 0.76

[Microbiologic studies of cysts and abscesses of Bartholin's gland]. Rev Fr Gynecol Obstet (1990) 0.76

Group F streptococcal bacteremia complicating a Bartholin's abscess. Infect Dis Obstet Gynecol (2001) 0.76

Articles by these authors

CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect (2012) 4.68

Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science (2001) 4.61

Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol (1997) 3.57

Treatment of older patients with mantle-cell lymphoma. N Engl J Med (2012) 3.46

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J Virol (2000) 3.10

Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol (1998) 3.02

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill (2013) 2.63

Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood (2001) 2.50

Endoscopic snare excision of "giant" colorectal polyps. Gastrointest Endosc (1996) 2.42

Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia (2006) 2.38

Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc (1999) 2.36

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat Med (1999) 2.24

Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis (2000) 2.22

Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection (2012) 2.02

Measurement of the rate of nu(e) + d --> p + p + e(-) interactions produced by (8)B solar neutrinos at the Sudbury Neutrino Observatory. Phys Rev Lett (2001) 1.88

Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem (1995) 1.86

Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis (2012) 1.79

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG). Leukemia (2004) 1.68

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia (2012) 1.68

The Tannenbaum stent: a new plastic biliary stent without side holes. Am J Gastroenterol (1995) 1.61

Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother (2010) 1.56

Primary precutting versus conventional over-the-wire sphincterotomy for bile duct access: a prospective randomized study. Endoscopy (2006) 1.53

High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene Ther (1995) 1.52

Advantages of short-lived positron-emitting radioisotopes for intracoronary radiation therapy with liquid-filled balloons to prevent restenosis. J Nucl Med (2001) 1.52

Transpapillary and transmural drainage of pancreatic pseudocysts. Gastrointest Endosc (1995) 1.51

Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients. Clin Infect Dis (1999) 1.50

Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg Infect Dis (1999) 1.48

[S3-guidelines--sedation in gastrointestinal endoscopy]. Z Gastroenterol (2008) 1.47

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Mol Ther (2001) 1.47

Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2011) 1.42

Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment. Am J Clin Nutr (1999) 1.42

Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy. Br J Cancer (2010) 1.42

Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment. Blood (2001) 1.41

[Expertise of current trends and future perspectives in rehabilitation research in Germany]. Rehabilitation (Stuttg) (2007) 1.41

Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum. Endoscopy (1999) 1.41

[Vaccination against rabies: how and when?]. Dtsch Med Wochenschr (2012) 1.41

[Linezolid--a new antibiotic for treatment of methicillin resistant Staphylococcus aureus infections in trauma surgery? Report of 2 cases]. Unfallchirurg (2002) 1.40

Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol (1997) 1.39

[62-year-old patient with chronic lymphatic leukaemia and persistent fever in chemotherapy induced bone marrow aplasia. Angioinvasive aspergillosis]. Dtsch Med Wochenschr (2011) 1.39

Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. Cancer Res (1996) 1.36

Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc Natl Acad Sci U S A (2001) 1.35

A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect (2007) 1.33

Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL. J Biol Chem (1994) 1.33

Endoscopic pancreatic stent drainage in chronic pancreatitis and a dominant stricture: long-term results. Endoscopy (1995) 1.31

Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis (2003) 1.29

Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines. Blood (2000) 1.29

Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort. J Antimicrob Chemother (2010) 1.28

A powerful DNA extraction method and PCR for detection of microsporidia in clinical stool specimens. Clin Diagn Lab Immunol (1999) 1.26

Retroperitoneal endoscopic debridement for infected peripancreatic necrosis. Lancet (2000) 1.26

Acinetobacter bacteremia in the tropics. Clin Infect Dis (1999) 1.26

Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia (2007) 1.25

Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation. Antimicrob Agents Chemother (2009) 1.24

Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol (1999) 1.24

Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients. Clin Pharmacol Ther (2008) 1.23

[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia. S-3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy]. Pneumologie (2012) 1.23

Endoscopic ultrasound-guided cystogastrostomy. Endoscopy (2003) 1.22

Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood (1992) 1.21

Detection of microsporidia (Enterocytozoon bieneusi) in intestinal biopsy specimens from human immunodeficiency virus-infected patients by PCR. J Clin Microbiol (1995) 1.21

Receptor targeting of adeno-associated virus vectors. Gene Ther (2003) 1.20

CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. Blood (1999) 1.16

Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. Clin Microbiol Infect (2008) 1.16

Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis. Leukemia (2009) 1.16

Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. J Hosp Infect (2007) 1.16

TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations. Leukemia (2010) 1.15

Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect (2011) 1.14

Detection of the adrenal glands by endoscopic or transabdominal ultrasound. Endoscopy (1997) 1.14

CMV-antigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.14

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL. Leukemia (2012) 1.14

Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial. Leukemia (2008) 1.13

Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci (2010) 1.13

Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in. Leukemia (2012) 1.13

Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Ther (2003) 1.12

Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy. J Infect Dis (2010) 1.11

The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr. J Biol Chem (1997) 1.10

[The Bremen mortality index]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2004) 1.10

Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Cancer Care (Engl) (2010) 1.10

[SARS--Severe Acute Respiratory syndrome]. Pneumologie (2003) 1.09

[Ultrasound diagnosis of penicillin-induced segmental hemorrhagic colitis]. Dtsch Med Wochenschr (2000) 1.08

Detection of microsporidia in travelers with diarrhea. J Clin Microbiol (2001) 1.07

Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol (1997) 1.07

Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009). Clin Microbiol Infect (2012) 1.07

The Hawthorne effect: can it be measured and utilized? Br J Anaesth (2013) 1.07

Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol (2003) 1.07

Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5'-triphosphate in comparison to cellular DNA polymerases alpha and beta. Biochem Biophys Res Commun (1987) 1.06

CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential. Clin Exp Immunol (2008) 1.05

Paradoxical expansion of intracranial tuberculomas during chemotherapy. J Infect (1997) 1.05

Septic arthritis due to Rothia mucilaginosa. Infection (2010) 1.04

Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine. Biochem Biophys Res Commun (1988) 1.04

Papillary roof incision using the Erlangen-type pre-cut papillotome to achieve selective bile duct cannulation. Gastrointest Endosc (1996) 1.04

Structured parent education in the management of childhood atopic dermatitis: the Berlin model. Patient Educ Couns (2000) 1.04

Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies. Ann Hematol (1999) 1.02

Test-ordering by multiple physicians increases unnecessary laboratory examinations. Arch Pathol Lab Med (1988) 1.02

Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur J Clin Microbiol Infect Dis (2003) 1.01

Right hemihepatectomy for bile duct injury following laparoscopic cholecystectomy. Surg Endosc (2003) 1.00